Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Adrenal Cancer

pyrroles has been researched along with Adrenal Cancer in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.70)18.7374
1990's0 (0.00)18.2507
2000's6 (22.22)29.6817
2010's20 (74.07)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Addioui, A; Beaunoyer, M; Belounis, A; Cournoyer, S; Haddad, E; Le Gall, R; Nyalendo, C; Sartelet, H; Teira, P; Vassal, G1
Bullova, P; Cougnoux, A; Kopacek, J; Marzouca, G; Pacak, K1
Bergman, PJ; Johannes, CM; Musser, ML; Taikowski, KL1
Inoue, T; Kawakita, S; Kinoshita, H; Masuda, T; Matsuda, T; Murota, T; Nishida, T1
Kowalewicz-Kulbat, M; Lawnicka, H; Melen-Mucha, G; Motylewska, E; Niedziela, A; Sicinska, P; Stepien, H1
Asa, SL; Cassol, CA; Ezzat, S; Guo, M; Liu, W; Winer, D1
Akaihata, H; Haga, N; Hata, J; Ishibashi, K; Kataoka, M; Koguchi, T; Kojima, Y; Ogawa, S; Satoh, Y; Takahashi, N1
Hamada, A; Kato, K; Kawanishi, H; Okumura, K; Sawada, A; Sunada, T1
Anouar, Y; Baudin, E; Denorme, M; Dubessy, C; Gonzalez, BJ; Roux, C; Yon, L1
Cai, X; Liu, J; Luo, J; Song, Y; Wang, L; Xu, H; Xu, S; Zhang, S1
Bobrzyk, M; Chronowska, J; Kukla, U; Madej, P; Okopień, B; Łabuzek, K1
Makis, W; McCann, K; McEwan, AJ; Sawyer, MB1
Coakley, FV; Costantino, C; Ryan, C; Thomas, GV; Troxell, ML1
Harisinghani, MG; Iliopoulos, O; McDermott, DF; McGovern, FJ; Michaelson, MD; Oliva, E1
Asa, SL; Broom, R; Evans, A; Ezzat, S; Freeman, M; Joshua, AM; Knox, JJ1
Cabanillas, ME; Jimenez, C; Jonasch, E; Kyle, KL; Lano, EA; Matin, SF; Nunez, RF; Perrier, ND; Phan, A; Rich, TA; Santarpia, L; Shah, B; Waguespack, SG; Williams, MD1
Ahn, H; Ahn, JH; Choi, JS; Kim, TW; Kim, YR; Koh, JM; Lee, DH; Lee, JL; Lee, JS; Park, I; Park, KS; Park, TS1
Bornstein, SR; Brown, JW; Ehrhart-Bornstein, M; Eisenhofer, G; Engel, JB; Erler, A; Fishman, LM; Gebauer, L; Petersenn, S; Schally, AV; Treszl, A; Willenberg, HS; Young, L; Ziegler, CG1
Ayllon, J; Barrascout, E; Beuselinck, B; Medioni, J; Morel, A; Oudard, S; Scotte, F1
Ikeda, A; Iwasaki, H; Kawai, K; Kimura, T; Kojima, T; Miyazaki, J; Nishiyama, H; Oikawa, T; Shimano, H; Suetomi, T; Takaoka, E; Yoshino, T1
Miura, T; Nemoto, K; Shioji, G; Tsuboi, N1
Dai, J; He, HC; Huang, X; Shen, ZJ; Su, TW; Sun, FK; Zhou, WL1
Al Ghuzlan, A; Anderson, P; Ayala-Ramirez, M; Baudin, E; Cabanillas, ME; Caramella, C; Chougnet, CN; Deandreis, D; Habra, MA; Jimenez, C; Leboulleux, S; Palmer, JL; Waguespack, SG1
Bergmann, R; Bornstein, SR; Ehrhart-Bornstein, M; Eisenhofer, G; Gebauer, L; Gondek, K; Pacak, K; Pietzsch, J; Qin, N; Schally, AV; Ullrich, M; Ziegler, CG1
Hara, H; Ikeda, T; Ishii, KA; Kawakami, Y; Miura, M; Otagiri, A; Saito, Y; Shimano, H; Takekoshi, K1
Dominici, C; Mancini, C; Mancuso, M; McDowell, HP; Raschellà, G; Tanno, B; Vitali, R1
Schein, PS1

Reviews

1 review(s) available for pyrroles and Adrenal Cancer

ArticleYear
Chemotherapeutic management of the hormone-secreting endocrine malignancies.
    Cancer, 1972, Volume: 30, Issue:6

    Topics: Adenoma, Islet Cell; Adrenal Gland Neoplasms; Aminoglutethimide; Aniline Compounds; Antibiotics, Antineoplastic; Antineoplastic Agents; Butanones; Carcinoid Tumor; Diazoxide; Humans; Hypoglycemia; Insulin Antagonists; Kidney Tubules; Metyrapone; Mitotane; Neoplasm Metastasis; Pheochromocytoma; Pyrimidines; Pyrroles; Pyrrolidines; Ribonucleosides; Serotonin Antagonists; Streptozocin

1972

Other Studies

26 other study(ies) available for pyrroles and Adrenal Cancer

ArticleYear
GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
    BMC cancer, 2019, Oct-29, Volume: 19, Issue:1

    Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Hydroxychloroquine; Indoles; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Tumor Burden; Xenograft Model Antitumor Assays

2019
Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.
    Endocrinology, 2017, 10-01, Volume: 158, Issue:10

    Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bortezomib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Female; Lactones; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Pheochromocytoma; Proteasome Inhibitors; Pyrroles

2017
Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).
    BMC veterinary research, 2018, Sep-03, Volume: 14, Issue:1

    Topics: Adrenal Gland Neoplasms; Animals; Dog Diseases; Dogs; Female; Indoles; Male; Pheochromocytoma; Pyrroles; Retrospective Studies; Treatment Outcome

2018
[Pre- surgical therapy with sunitinib for adrenal metastasis from renal cell carcinoma : a case report].
    Hinyokika kiyo. Acta urologica Japonica, 2013, Volume: 59, Issue:9

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Female; Humans; Indoles; Kidney Neoplasms; Middle Aged; Preoperative Care; Pyrroles; Sunitinib; Treatment Outcome

2013
Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro.
    Endokrynologia Polska, 2013, Volume: 64, Issue:5

    Topics: Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Proliferation; Endostatins; Growth Hormone-Releasing Hormone; Indoles; Interferon-alpha; Neovascularization, Pathologic; PC12 Cells; Pheochromocytoma; Pyrroles; Rats; Sirolimus; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2013
Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2014, Volume: 27, Issue:8

    Topics: Adrenal Gland Neoplasms; Adult; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Design; Female; Humans; Immunohistochemistry; Indoles; Male; Mice; Middle Aged; Molecular Targeted Therapy; Mutation; Paraganglioma; Pheochromocytoma; Polymorphism, Single Nucleotide; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Succinate Dehydrogenase; Sunitinib; Tissue Array Analysis

2014
Sunitinib for refractory malignant pheochromocytoma: two case reports.
    International urology and nephrology, 2014, Volume: 46, Issue:7

    Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Humans; Immunohistochemistry; Indoles; Liver Neoplasms; Male; Middle Aged; Pheochromocytoma; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A; Young Adult

2014
[A case of adrenal metastasectomy in renal cell carcinoma after neoadjuvant therapy with sunitinib].
    Hinyokika kiyo. Acta urologica Japonica, 2014, Volume: 60, Issue:2

    Topics: Adrenal Gland Neoplasms; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Pyrroles; Sunitinib

2014
Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
    Cancer letters, 2014, Oct-01, Volume: 352, Issue:2

    Topics: Administration, Oral; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Survival; Dose-Response Relationship, Drug; Heterografts; Indoles; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Niacinamide; PC12 Cells; Phenylurea Compounds; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Rats; Sorafenib; Sunitinib; Time Factors; Tumor Burden

2014
Carbon fiber ultramicrodic electrode electrodeposited with over-oxidized polypyrrole for amperometric detection of vesicular exocytosis from pheochromocytoma cell.
    Sensors (Basel, Switzerland), 2015, Jan-06, Volume: 15, Issue:1

    Topics: Adrenal Gland Neoplasms; Animals; Carbon; Carbon Fiber; Dopamine; Electrochemical Techniques; Electrodes; Electroplating; Exocytosis; Oxidation-Reduction; Pheochromocytoma; Polymers; Pyrroles; Rats; Signal-To-Noise Ratio; Time Factors; Transport Vesicles

2015
[Antiangiogenic therapy of malignant pheochromocytoma and paraganglioma with the view to the recent scientific developments].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2015, Volume: 38, Issue:226

    Topics: Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Benzamides; Humans; Imatinib Mesylate; Indoles; Neovascularization, Pathologic; Paraganglioma; Pheochromocytoma; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sunitinib; Thalidomide

2015
Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:3

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Chemoradiotherapy; Female; Humans; Indoles; Mutation; Pheochromocytoma; Pyrroles; Remission Induction; Succinate Dehydrogenase; Sunitinib

2016
Metastatic renal cell carcinoma without evidence of a renal primary.
    International urology and nephrology, 2016, Volume: 48, Issue:1

    Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Diagnosis, Differential; Diagnostic Imaging; Humans; Immunohistochemistry; Indoles; Kidney Neoplasms; Liver Neoplasms; Lymph Node Excision; Male; Pyrroles; Sunitinib

2016
Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
    The New England journal of medicine, 2008, May-29, Volume: 358, Issue:22

    Topics: Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nephrectomy; Prognosis; Pyrroles; Sunitinib

2008
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:1

    Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Humans; Indoles; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Pyrroles; Sunitinib; Tomography, X-Ray Computed

2009
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:2

    Topics: Adrenal Gland Neoplasms; Adult; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Drug Delivery Systems; Female; Humans; Indoles; Neoplasms, Multiple Primary; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Treatment Outcome; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein

2009
Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma.
    Japanese journal of clinical oncology, 2009, Volume: 39, Issue:5

    Topics: Adolescent; Adrenal Gland Neoplasms; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Humans; Indoles; Liver Neoplasms; Male; Mediastinal Neoplasms; Pheochromocytoma; Pyrroles; Sunitinib

2009
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Sep-15, Volume: 106, Issue:37

    Topics: 2-Hydroxyphenethylamine; Adrenal Gland Neoplasms; Adrenal Glands; Aniline Compounds; Animals; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Doxorubicin; Gene Expression; Humans; Neuropeptides; Oligonucleotide Array Sequence Analysis; PC12 Cells; Pyrroles; Rats; Receptors, LHRH; Receptors, Neuropeptide; Receptors, Somatostatin; RNA, Messenger; Somatostatin

2009
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma.
    Cancer investigation, 2011, Volume: 29, Issue:4

    Topics: Administration, Oral; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Angiogenesis Inhibitors; Bone Neoplasms; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Female; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Staging; Nephrectomy; Osteotomy; Pneumonectomy; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Time Factors; Treatment Outcome

2011
A case of acute adrenal insufficiency unmasked during sunitinib treatment for metastatic renal cell carcinoma.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:8

    Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Pyrroles; Sunitinib; Thyroid Function Tests; Thyrotoxicosis

2012
Sunitinib treatment for refractory malignant pheochromocytoma.
    Neuro endocrinology letters, 2012, Volume: 33, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Indoles; Pheochromocytoma; Pyrroles; Radiography; Radionuclide Imaging; Sunitinib; Treatment Outcome

2012
Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma.
    Chinese medical journal, 2012, Volume: 125, Issue:12

    Topics: Adrenal Gland Neoplasms; Adult; Female; Humans; Indoles; Male; Middle Aged; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Sunitinib

2012
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:11

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Pyrroles; Retrospective Studies; Sunitinib; Treatment Outcome

2012
Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.
    Molecular and cellular endocrinology, 2013, May-22, Volume: 371, Issue:1-2

    Topics: 2-Hydroxyphenethylamine; Adrenal Gland Neoplasms; Aniline Compounds; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Mice; Pheochromocytoma; Pyrroles; Receptors, LHRH; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Receptors, Somatostatin; Sermorelin; Somatostatin

2013
Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells.
    Journal of pharmacological sciences, 2013, Volume: 121, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Indoles; Mechanistic Target of Rapamycin Complex 1; Microtubule-Associated Proteins; Molecular Targeted Therapy; Multiprotein Complexes; PC12 Cells; Pheochromocytoma; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Pyrroles; Rats; Signal Transduction; Sunitinib; TOR Serine-Threonine Kinases

2013
Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-15, Volume: 12, Issue:22

    Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Down-Regulation; Humans; Kidney Neoplasms; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neuroblastoma; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Transplantation, Heterologous; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2006